Stock DVYSR DEVYSER DIAGNOSTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Devyser Diagnostics AB

Equities

DVYSR

SE0016588867

Delayed Nasdaq Stockholm
Other stock markets
 12:00:00 2024-06-11 pm EDT 		5-day change 1st Jan Change
110 SEK 0.00% Intraday chart for Devyser Diagnostics AB -0.90% +39.95%
May. 30 Devyser Wins Tender for Oncology NGS Solutions in Italy CI
May. 27 Devyser Wins Tender for Thalassemia in Italy CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Devyser Wins Tender for Oncology NGS Solutions in Italy
CI
Devyser Wins Tender for Thalassemia in Italy
CI
Devyser Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Devyser Receives IVDR Approval for Post-Transplant Monitoring Software
CI
Devyser Diagnostics AB Enters into Co-Marketing Agreement with Hamilton Bonaduz AG
CI
Devyser Diagnostics AB Achieves Breakthrough in the US with Cystic Fibrosis NGS Test
CI
Devyser Diagnostics AB Announces Study Publication Demonstrating dd-cfDNA Detection in Dual Donor Kidney Transplant Patient
CI
Devyser Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Devyser Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Devyser's US Lab Inks SEK25 Million Deal with UK Diagnostics Company Cyted
MT
Devyser Genomic Laboratories Signs First Commercial Agreement with Cyted
CI
Sweden’s Devyser Wins SEK1.5 Million Tender in Italy for Cystic Fibrosis Test Kits
MT
Devyser Diagnostics AB Wins Tender for Cystic Fibrosis in Italy
CI
Devyser Diagnostics Teams Up with Illumina to Offer IVD Tests in Europe, US
MT
Devyser Diagnostics AB Signs in Vitro Diagnostic Agreement with Illumina to Broaden Access to Its Tests
CI
Sweden’s Devyser Wins $6 Million Tender for Cystic Fibrosis Diagnostic Tool in Italy
MT
Devyser Wins Approximately SEK 2 Million Tender for Cystic Fibrosis
CI
Devyser Diagnostics Bags Non-invasive Fetal RHD Test Tender in Wales
MT
Devyser wins tender for non-invasive fetal RHD testing in Wales
CI
Devyser Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DVYSR Stock
  4. News Devyser Diagnostics AB
  5. Highlights